{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:41:21Z","timestamp":1756464081936,"version":"3.41.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Homoharringtonine (HHT) is an effective anti-inflammatory, anti-viral, and anti-tumor protein synthesis inhibitor that has been applied clinically. Here, we explored the therapeutic effects of HHT in a mouse heart transplant model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Healthy C57BL\/6 mice were used to observe the toxicity of HHT in the liver, kidney, and hematology. A mouse heart transplantation model was constructed, and the potential mechanism of HHT prolonging allograft survival was evaluated using Kaplan\u2013Meier analysis, immunostaining, and bulk RNA sequencing analysis. The HHT-T cell crosstalk was modeled <jats:italic toggle=\"yes\">ex vivo<\/jats:italic> to further verify the molecular mechanism of HHT-induced regulatory T cells (Tregs) differentiation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>HHT inhibited the activation and proliferation of T cells and promoted their apoptosis <jats:italic toggle=\"yes\">ex vivo<\/jats:italic>. Treatment of 0.5 mg\/kg HHT for 10 days significantly prolonged the mean graft survival time of the allografts from 7 days to 48 days (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.001) without non-immune toxicity. The allografts had long-term survival after continuous HHT treatment for 28 days. HHT significantly reduced lymphocyte infiltration in the graft, and interferon-\u03b3-secreting CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells in the spleen (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.01). HHT significantly increased the number of peripheral Tregs (about 20%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.001) and serum interleukin (IL)-10 levels. HHT downregulated the expression of T cell receptor (TCR) signaling pathway-related genes (<jats:italic toggle=\"yes\">CD4<\/jats:italic>, <jats:italic toggle=\"yes\">H2-Eb1<\/jats:italic>, <jats:italic toggle=\"yes\">TRAT1<\/jats:italic>, and <jats:italic toggle=\"yes\">CD74<\/jats:italic>) and upregulated the expression of IL-10 and transforming growth factor (TGF)-\u03b2 pathway-related genes and Treg signature genes (<jats:italic toggle=\"yes\">CTLA4<\/jats:italic>, <jats:italic toggle=\"yes\">Foxp3<\/jats:italic>, <jats:italic toggle=\"yes\">CD74<\/jats:italic>, and <jats:italic toggle=\"yes\">ICOS<\/jats:italic>). HHT increased CD4<jats:sup>+<\/jats:sup> Foxp3<jats:sup>+<\/jats:sup> cells and Foxp3 expression <jats:italic toggle=\"yes\">ex vivo<\/jats:italic>, and it enhanced the inhibitory function of inducible Tregs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>HHT promotes Treg cell differentiation and enhances Treg suppressive function by attenuating the TCR signaling pathway and upregulating the expression of Treg signature genes and IL-10 levels, thereby promoting mouse heart allograft acceptance. These findings may have therapeutic implications for organ transplant recipients, particularly those with viral infections and malignancies, which require a more suitable anti-rejection medication.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002813","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T13:06:28Z","timestamp":1699967188000},"page":"1453-1464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model"],"prefix":"10.1097","volume":"137","author":[{"given":"Xia","family":"Qiu","sequence":"first","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"},{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouqi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"},{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Cui","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"},{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"},{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongquan","family":"Qi","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengfang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"},{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Xie","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuo","family":"Deng","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan 450000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longkai","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"},{"name":"National Clinical Research Center for Metabolic Diseases, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helong","family":"Dai","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"},{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"},{"name":"Department of Organ Transplantation, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan 450000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: Managing the \"Net State of Immunosuppression\"","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/jo01044a010","article-title":"The Alkaloids of Cephalotaxus drupacea and Cephalotaxus fortunei","volume":"28","author":"Paudler","year":"1963","journal-title":"J Org Chem"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0040-4039(01)88620-2","article-title":"Structure of cephalotaxine and related alkaloids","volume":"10","author":"Powell","year":"1969","journal-title":"Tetrahedron Lett"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0040-4039(01)97839-6","article-title":"Structures of harringtonine, isoharringtonine, and homoharringtonine","volume":"11","author":"Powell","year":"1970","journal-title":"Tetrahedron Lett"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U","article-title":"Homoharringtonine: History, current research, and future direction","volume":"92","author":"Kantarjian","year":"2001","journal-title":"Cancer"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1016\/j.clml.2021.06.002","article-title":"Efficacy and safety of homoharringtonine for the treatment of acute myeloid leukemia: A meta-analysis","volume":"21","author":"Mi","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jmb.2009.04.005","article-title":"U2504 determines the species specificity of the A-site cleft antibiotics: The structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome","volume":"389","author":"G\u00fcrel","year":"2009","journal-title":"J Mol Biol"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature13737","article-title":"Structural basis for the inhibition of the eukaryotic ribosome","volume":"513","author":"Garreau de Loubresse","year":"2014","journal-title":"Nature"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.2018.208835","article-title":"Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1\/TET1\/5hmC","volume":"105","author":"Li","year":"2020","journal-title":"Haematologica"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"995","DOI":"10.7150\/ijbs.44907","article-title":"Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p\/AKT\/mTOR signaling pathway","volume":"17","author":"Wang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.1818539116","article-title":"Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-\u03baB repressing factor","volume":"116","author":"Chen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11427-021-2093-2","article-title":"Homo-harringtonine, highly effective against coronaviruses, is safe in treating COVID-19 by nebulization","volume":"65","author":"Ma","year":"2022","journal-title":"Sci China Life Sci"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000519974","article-title":"Homoharringtonine inhibits Alzheimer's disease progression by reducing neuroinflammation via STAT3 signaling in APP\/PS1 mice","volume":"21","author":"Jiang","year":"2021","journal-title":"Neurodegener Dis"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"3441357","DOI":"10.1155\/2022\/3441357","article-title":"Homoharringtonine attenuates dextran sulfate sodium-induced colitis by inhibiting NF-\u03baB signaling","volume":"2022","author":"Liu","year":"2022","journal-title":"Mediators Inflamm"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajh.20903","article-title":"Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia","volume":"83","author":"Zhang","year":"2008","journal-title":"Am J Hematol"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1158\/0008-5472.CAN-11-2739","article-title":"Targeting protein synthesis in a Myc\/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival","volume":"72","author":"Robert","year":"2012","journal-title":"Cancer Res"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fphar.2020.01032","article-title":"Homoharringtonine inhibits allergic inflammations by regulating NF-\u03baB-miR-183-5p-BTG1 axis","volume":"11","author":"Kim","year":"2020","journal-title":"Front Pharmacol"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clml.2013.03.017","article-title":"Homoharringtonine\/omacetaxine mepesuccinate: The long and winding road to Food and Drug Administration approval","volume":"13","author":"Kantarjian","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"12940","DOI":"10.1080\/21655979.2021.2012626","article-title":"Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation","volume":"12","author":"Qu","year":"2021","journal-title":"Bioengineered"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1172\/JCI133008","article-title":"Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Invest"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-8722-7-2","article-title":"Homoharringtonine and omacetaxine for myeloid hematological malignancies","volume":"7","author":"L\u00fc","year":"2014","journal-title":"J Hematol Oncol"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.immuni.2019.05.014","article-title":"Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells","volume":"51","author":"Tibbitt","year":"2019","journal-title":"Immunity"},{"key":"R24-20250602","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.149","article-title":"Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor","volume":"3","author":"Lindqvist","year":"2012","journal-title":"Cell Death Dis"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","article-title":"Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma","volume":"290","author":"Badovinac","year":"2000","journal-title":"Science"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41467-021-21594-6","article-title":"METTL3-dependent m6A modification programs T follicular helper cell differentiation","volume":"12","author":"Yao","year":"2021","journal-title":"Nat Commun"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pcl.2010.01.008","article-title":"Nonimmune complications after transplantation","volume":"57","author":"Choquette","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"10930","DOI":"10.3390\/ijms222010930","article-title":"TMEM16A, a homoharringtonine receptor, as a potential endogenic target for lung cancer treatment","volume":"22","author":"Guo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11684-018-0624-1","article-title":"Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia","volume":"13","author":"Zhang","year":"2019","journal-title":"Front Med"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/leu.2009.52","article-title":"Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice","volume":"23","author":"Chen","year":"2009","journal-title":"Leukemia"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tranon.2019.02.016","article-title":"Homoharringtonine combined with the heat shock protein 90 inhibitor IPI504 in the treatment of FLT3-ITD acute myeloid leukemia","volume":"12","author":"Wu","year":"2019","journal-title":"Transl Oncol"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/v11100964","article-title":"Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine","volume":"11","author":"Andersen","year":"2019","journal-title":"Viruses"},{"issue":"Pt B","key":"R33-20250602","doi-asserted-by":"crossref","first-page":"108218","DOI":"10.1016\/j.intimp.2021.108218","article-title":"Combination of matrine and tacrolimus alleviates acute rejection in murine heart transplantation by inhibiting DCs maturation through ROS\/ERK\/NF-\u03baB pathway","volume":"101","author":"Zheng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1158\/1078-0432.CCR-19-2717","article-title":"Rhabdoid tumors are sensitive to the protein-translation inhibitor homoharringtonine","volume":"26","author":"Howard","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/jmv.25494","article-title":"Inhibitory effects of homoharringtonine on foot and mouth disease virus in vitro","volume":"91","author":"Gong","year":"2019","journal-title":"J Med Virol"},{"key":"R36-20250602","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026763118","article-title":"Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus","volume":"118","author":"Iriki","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.168.3.1080","article-title":"CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses","volume":"168","author":"Kingsley","year":"2002","journal-title":"J Immunol"},{"key":"R38-20250602","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012305","article-title":"IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival","volume":"12","author":"Huang","year":"2020","journal-title":"EMBO Mol Med"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20091999","article-title":"TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo","volume":"207","author":"Gottschalk","year":"2010","journal-title":"J Exp Med"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.it.2014.06.005","article-title":"Post-translational modification networks regulating FOXP3 function","volume":"35","author":"van Loosdregt","year":"2014","journal-title":"Trends Immunol"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.imlet.2012.09.002","article-title":"CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity","volume":"148","author":"Chen","year":"2012","journal-title":"Immunol Lett"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:06:44Z","timestamp":1748891204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002813","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"type":"print","value":"0366-6999"},{"type":"electronic","value":"2542-5641"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"2023-07-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}